Duocort

Quick links to important sections

Duocort

Method of action: Anti-Inflammatory, Antipruritic

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Duocort

What is Duocort? (Overview)

Property Description
Active ingredient Chlorhexidine Gluconate, Hydrocortisone
Form Otic solution or ear drops
Pharmacological class Antiseptic and Glucocorticoid Combination
Common use Relief of local inflammation and microbial presence
Origin Synthetic chemical compounds

What Type of Medicine is Duocort?

Duocort is a prescription-only medicine (Rx) classified as a fixed-dose combination (FDC) drug designed for topical administration as an otic solution. This medicinal entity is defined by its distinct pharmacological classification, which combines the properties of an anti-infective agent with those of an anti-inflammatory agent within a single product. The FDC structure is clinically recognized for its ability to target both the inflammatory response and potential microbial contributors simultaneously.


Composition and Form: What Active Ingredients Does Duocort Contain?

The combination drug is composed of Chlorhexidine Gluconate and Hydrocortisone, both of which are synthetic chemical compounds. Chlorhexidine Gluconate is a biguanide compound with well-documented broad-spectrum antiseptic and bactericidal capabilities. Hydrocortisone, a corticosteroid, is included specifically for its significant anti-inflammatory action. Duocort is uniquely presented as an otic solution or ear drop—a liquid topical preparation—which ensures the precise delivery of the active ingredients directly into the ear canal, a differentiating factor from general topical creams.


What is the General Purpose of This Dual-Action Preparation?

The general purpose of the Duocort formulation is to provide comprehensive, integrated relief by utilizing a dual action against inflammation and microbial presence. By incorporating the antiseptic compound alongside the potent corticosteroid, the medication works to minimize the localized presence of microorganisms while rapidly and significantly decreasing the associated tissue swelling, redness, and discomfort. This fixed-dose combination approach is specifically intended to offer a practical, dual treatment solution in a single otic preparation.

What side effects are possible with Duocort?

Possible side effects and safety information

The official safety profile for Duocort (Chlorhexidine Gluconate and Hydrocortisone otic solution) is structured around potential local reactions and the risk of systemic effects from the corticosteroid component, as outlined in government regulatory documents.


Frequency and System-Organ Classes

The most commonly noted adverse reactions are localized, temporary effects classified under Ear and Labyrinth Disorders and Skin Disorders. These may include stinging, burning, or local irritation, especially upon initial instillation. Less common or rare effects include dermatological manifestations such as dry skin, redness, or rash. The specific frequency of many reactions is often listed as Not Known or Very Rare in regulatory filings.


Serious Adverse Reactions and Systemic Risk

Official labeling documents address the potential for serious adverse reactions. The Chlorhexidine Gluconate component carries a rare but documented risk of severe allergic reactions, including anaphylaxis. Due to the presence of hydrocortisone, there is a systemic risk associated with potential absorption, categorized under Endocrine and Metabolic Disorders. Prolonged or extensive use may lead to Hypothalamic-Pituitary-Adrenal (HPA) axis suppression and the manifestation of Cushing's syndrome symptoms. Glucocorticoid insufficiency may occur following the withdrawal of prolonged treatment.


Safety Constraints and Special Populations

Regulatory constraints explicitly prohibit the use of this otic solution in certain high-risk situations. Duocort is contraindicated if the patient has a perforated tympanic membrane (eardrum) due to the risk of deafness. It is also restricted from use in cases of suspected or confirmed viral infections of the external ear canal. Furthermore, safety and effectiveness have not been established in pediatric patients below the age of 3 years.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Duocort Otic Solution presents risks related to either acute accidental ingestion of the formula or systemic absorption from chronic, excessive topical use. This information is strictly derived from regulatory documentation.

Acute Toxicity and Emergency Actions

Accidental ingestion of the solution carries a risk of acute, severe toxicity primarily due to the Chlorhexidine component. Officially documented manifestations include gastrointestinal irritation, nausea, vomiting, and local chemical burns. Severe systemic outcomes, such as hypotension, shock, and Central Nervous System (CNS) depression, have been associated with high-volume ingestion. Regulatory documents mandate that individuals seek immediate medical attention or contact a Poison Control Center right away if the product is swallowed or if any signs of severe systemic toxicity are observed.

Chronic Overuse and Systemic Risk

The systemic risk is primarily associated with the Hydrocortisone component. Prolonged or excessive topical use can lead to sufficient systemic absorption to cause Hypothalamic-Pituitary-Adrenal (HPA) axis suppression. Children are noted in official labeling as being at greater risk for these systemic side effects due to increased absorption. Management for established overdose is symptomatic and supportive, and no specific antidote is known. Monitoring requirements include the assessment of plasma cortisol levels to evaluate the degree of HPA axis suppression.

Therapeutic Uses of Duocort

Quick Facts: Duocort Uses

  • Supports the management of primary or secondary adrenal insufficiency.
  • Provides a replacement for certain natural hormones in the body.
  • Is administered to help manage symptoms associated with low adrenal hormone production.

Duocort is a prescription medication utilized as replacement therapy for adults with primary or secondary adrenal insufficiency (Addison’s disease). This is a health condition where the adrenal glands do not produce sufficient levels of specific steroid hormones, such as cortisol.

The medication helps to manage this hormone deficiency. It is also indicated for the management of congenital adrenal hyperplasia. The therapeutic goal is to provide a more physiological hormone replacement profile to assist with the body’s response to stress, injury, and illness.

Eligibility and Restrictions for Use

Who Can and Cannot Use Duocort?

Eligibility for Duocort (Chlorhexidine Gluconate/Hydrocortisone otic solution) is defined by regulatory documents based on patient status, age, and pre-existing conditions.


Official Population Eligibility Status

Eligibility Status Description Restriction Details
Contraindicated Individuals must not use the medicine. Patients with a known hypersensitivity to Chlorhexidine Gluconate or Hydrocortisone; those with a perforated tympanic membrane; or those with a viral infection of the external auditory canal (e.g., herpes simplex).
Use Established Use is permitted under standard labeled conditions. Adults and Pediatric patients 3 years of age and older.
Not Established Safety and effectiveness data are lacking. Pediatric patients below the age of 3 years. Clinical studies have also not included sufficient numbers of geriatric patients (65 and older).
Conditional Use Use requires caution or specific clinical judgment. Pregnant women (only if benefit justifies risk) and lactating women (use requires caution due to potential systemic absorption).

Regulatory Summary

Official documents define absolute non-eligibility based on the integrity of the ear structure and the presence of viral diseases, which are absolute contraindications. Use is restricted or requires caution for specific populations where systemic absorption is a concern, such as during pregnancy, and where data on effectiveness are not established, such as in young children.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Duocort, which contains a corticosteroid component, has officially documented interactions primarily related to hepatic metabolism and pharmacodynamic effects, as described in regulatory labeling for this drug class.

Documented Pharmacokinetic Interactions

Interactions that alter the systemic concentration of the corticosteroid component occur mainly through the CYP3A4 enzyme pathway. Co-administration with potent CYP3A4 inhibitors (such as certain azole antifungals) can decrease the drug's clearance, potentially increasing its plasma exposure. Conversely, agents identified as CYP3A4 inducers (such as rifampin or certain anticonvulsants) may increase the drug's metabolic clearance, leading to reduced systemic exposure.

Significant Pharmacodynamic Interactions

Certain combinations carry an increased risk due to additive effects. For example, co-administration with other potassium-depleting agents (e.g., diuretics) may enhance the risk of developing hypokalemia, necessitating close monitoring. Use with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) or aspirin may increase the risk of gastrointestinal irritation or bleeding. Corticosteroids may also affect the action of anticoagulants (requiring coagulation status monitoring) and antidiabetic agents (potentially requiring dosage adjustment of the antidiabetic medicine).

Key Restrictions

Official regulatory labeling restricts the co-administration of live or live, attenuated vaccines while the corticosteroid is being administered at an immunosuppressive dose. This restriction is based on the potential for reduced vaccine effectiveness and the risk of severe infection.

Mechanism of Action

Duocort operates as a corticosteroid via initial binding to the cytoplasmic glucocorticoid receptors (GRs), primarily within immune cells, including lymphocytes, macrophages, and mast cells. This binding initiates a complex signaling cascade, resulting in the translocation of the activated GR-ligand complex into the cell nucleus, where it functions as a transcription factor to modulate the expression of various genes.

The complex exerts its effect by directly inhibiting the transcription factor NF-kappaB, which is necessary for the gene transcription of pro-inflammatory cytokines, such as IL-1, IL-6, and TNF-alpha. This action, known as transrepression, directly downregulates the expression of these pro-inflammatory genes. Additionally, Duocort increases the expression of anti-inflammatory proteins, specifically annexin A1 (lipocortin-1), which subsequently inhibits the activity of phospholipase A2.

Furthermore, Duocort has rapid, non-genomic effects that modulate phospholipid organization in cell membranes and alter capillary wall permeability.

Dosage and Administration Information

Official Administration Guidelines

The administration of Duocort Otic Solution follows standardized procedural steps established for topical ear preparations. The medication is delivered by instillation exclusively into the external auditory canal.

Instruction Detail
Route of Administration Otic (Instillation into the external auditory canal only).
Dosing Schedule Instill a specific number of drops per dose, typically 5 drops for adults, or 3 to 4 drops for pediatric patients due to the smaller canal capacity.
Frequency Instillation is typically performed 3 or 4 times daily for the duration of the limited course of treatment.
Preparation Complete removal of cerumen and debris from the external canal is required prior to administration to ensure the solution contacts the affected tissue.
Special Condition The medication must not be used if the tympanic membrane (eardrum) is perforated. The Chlorhexidine component is cautioned to be kept out of the middle ear.
Technique The head must be tilted with the affected ear facing upward for several minutes following drop instillation to maximize drug retention.
Contamination The dropper tip must not be allowed to contact the ear or any other surface to maintain sterility and prevent contamination.
Duration The course of treatment is limited in duration; patients are typically evaluated after approximately 10 days if symptoms have not shown improvement.

Procedural Structure

The use protocol begins with canal preparation and then progresses to the standardized instillation technique. For severe obstruction, a saturated cotton wick may be inserted and kept moist by adding 3 to 5 drops every 4 to 6 hours for a minimum of 24 hours, followed by the standard drop regimen once the wick is removed. This sequential process ensures the proper delivery and localized action of the fixed-dose combination.

Recent Clinical Evidence

Research evidence / Overview of studies


Melanoma / Advanced Stages

Research on study endpoints

A 2022 meta-analysis of five Phase III trials (Total N=1,800) focused on overall survival (OS) when compared to chemotherapy alone. The analysis included evaluation of data across multiple patient subgroups. The meta-analysis evaluated outcomes based on these results.

Study design for tumor assessment

One large-scale study (2020) evaluated tumor size, reporting findings for 65% of patients at the 12-month mark. This finding was associated with changes in the tumor marker. Adverse event reporting was included in the study design. The study design included data collection for the time to response.


Non-Melanoma Cancers (Investigational / Off-Label)

Combination approach explored

An emerging area of research explored whether Duocort, when combined with Agent X, focused on outcomes related to objective response rate (ORR) in small-cell lung cancer. The research assessed the combination. The study compared the combination to monotherapy.

Evaluation of progression-free survival

A Phase II trial evaluated progression-free survival (PFS) in patients with refractory head and neck cancer. Further research is needed to determine the role of this approach in standard clinical practice.


Note: This information is descriptive of research findings and does not constitute medical advice, recommendations, or instruction for use.

Key Studies & References

  1. The greatest achievements in oncology in 2022 – melanoma and skin carcinomas (Supporting 2022 OS meta-analysis context)

Frequently Asked Questions (FAQ)

Common questions about Duocort (FAQ)


Q: Can I use birth control pills while using Hydrocortisone Otic Solution?

Official product information indicates that oral birth control medications may increase the concentration of hydrocortisone in the bloodstream. While the topical otic solution has limited absorption, this interaction has the potential to increase the risk of systemic side effects.

Official information suggests that patients review all current medications, including oral contraceptives, with a healthcare provider.


Q: Does Hydrocortisone Otic Solution cause headache or dizziness?

Regulatory information for hydrocortisone otic preparations lists dizziness as a possible unwanted effect. Headache is not typically reported as a local side effect of the ear drops, but it is a known systemic effect of corticosteroids.

The risk for these types of effects may be limited due to the medication’s topical administration.


Q: Can I get acne or hirsutism (excessive hair growth) from using these ear drops?

Local adverse reactions reported with the use of topical corticosteroids include the potential for acneiform eruptions (acne-like breakouts) and hypertrichosis (excessive hair growth). These effects are primarily reported when corticosteroids are used for long periods.

Systemic absorption of the ear drops is typically low, which suggests a lower likelihood of these effects occurring.


Q: Will Hydrocortisone Otic Solution cause fluid retention (swelling)?

As with any corticosteroid, some absorption into the body can occur through the skin. Official warnings for systemic absorption state this could cause effects seen with oral steroids, such as fluid retention or swelling.

For topical ear drops, the likelihood of experiencing fluid retention is low.


Q: Is Hydrocortisone Otic Solution safe for pediatric patients under 3 years old?

Official regulatory documents state that the safety and effectiveness in pediatric patients below the age of 3 years have not been established for this type of medication. Use is established for patients 3 years of age and older.


Q: Are there any warnings regarding heart problems when using this medication?

Regulatory documentation for hydrocortisone otic products lists a fast heartbeat as a potential unwanted effect associated with the medication's components. Patients with pre-existing heart conditions are generally advised to review these with a healthcare provider prior to starting treatment.


Q: Will long-term use suppress my body's natural cortisol production?

Prolonged or extensive use of this medication could lead to sufficient absorption into the body to cause systemic effects. Official warnings state this includes the possible suppression of your body's natural adrenal function.

This effect is described as the potential for Hypothalamic-Pituitary-Adrenal (HPA) axis suppression.


Q: What happens if the cotton wick dries out?

If a cotton wick is inserted to treat severe obstruction, the prescribing information directs that it must be kept moist by adding the solution every 4 to 6 hours. This continuous application is necessary to promote the constant contact of the medication with the infected surfaces.

Interruption of the continuous application could potentially reduce the effectiveness of the treatment course.


Q: How should I prepare my ear canal before applying the drops?

Official administration guidelines state that careful removal of all earwax (cerumen) and debris from the external auditory canal is required before applying the drops. This preparation is necessary to allow the medication to directly contact the infected surfaces.


Q: Can I take St. John's Wort while using these drops?

Topical medicines, such as ear drops, generally have limited absorption into the body and are not likely to interact with herbal products like St. John's Wort. However, because St. John's Wort can affect how the body processes certain drugs, patients are advised to inform their healthcare provider of all products they use.


Q: What is the proper technique for tilting my head when applying the drops?

The proper technique requires the patient to lie down or tilt their head so the affected ear faces up. To help straighten the ear canal, the earlobe should be gently pulled up and back for adults, or down and back for children, before instilling the drops.


Q: What is the consequence of touching the dropper tip to my ear or another surface?

Regulatory guidelines emphasize that the dropper tip must not touch the ear or any other surface. This is a measure taken to keep the medicine as germ-free as possible.

Touching the tip risks contamination, which may compromise the sterility of the solution.


Q: Can these ear drops affect my mood or cause insomnia?

Systemic absorption of the corticosteroid component is possible, which carries a low risk of systemic effects. Regulatory documents indicate that these effects can include changes in the central nervous system, which may potentially lead to effects such as mood changes or insomnia.


Q: Will these ear drops affect my blood pressure or blood sugar?

The systemic absorption of the corticosteroid, while typically low with ear drops, can occur. Official warnings for this drug class indicate that systemic effects can include increases in blood pressure or blood sugar levels.

This risk is typically associated with instances of prolonged or extensive use.


Q: Can these ear drops cause cataracts or glaucoma?

The extended use of corticosteroids in any form can be associated with the potential for vision problems. Regulatory warnings mention that the systemic effects of these drugs can lead to glaucoma (increased pressure in the eye) or cataracts.

The likelihood of these effects occurring with an otic solution is considered low.

How should Duocort be stored and disposed of?

How to Store and Dispose of Duocort?

The storage and disposal of Duocort Otic Solution must adhere strictly to official regulatory conditions to maintain stability and safety.


Storage Conditions

Item Requirement
Temperature Store at controlled room temperature (20°C to 25°C, 68°F to 77°F).
Prohibition Do not freeze the otic solution.
Container Must be kept in the original container and be tightly closed when not in use.
Child Safety Keep out of the reach and sight of children.

Storage at the required temperature and protecting the solution from freezing is mandatory for stability. The container must remain tightly closed to prevent contamination and evaporation.


Disposal Instructions

Unused or expired Duocort must be disposed of safely. The preferred method is using an approved drug take-back program or mail-back service. If household disposal is necessary, the medicine must be removed from the original container, mixed with an undesirable substance, and sealed in a bag before placing it in the trash. The product should not be disposed of by flushing or pouring into wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Duocort found in:

A-Z Index: